Journal Article

Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines

Qiang Liu, S.T.F. Chan and Ratha Mahendran

in Carcinogenesis

Volume 24, issue 4, pages 637-642
Published in print April 2003 | ISSN: 0143-3334
Published online April 2003 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgg014
Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

The role of nitric oxide (NO) in colon cancer remains controversial. Inducible nitric oxide synthase (iNOS) has been reported to be up regulated and down regulated in colorectal cancer in both animal models and patient tissue samples. Cyclooxygenase-2 (COX-2) is important in colorectal carcinogenesis but its relationship with NO has never been studied in colon cancer. Three colon cancer cell lines (HCA7, HT29 and HCT116) with different COX-2 expression and activities were used to study the effect of the NO donor, S-nitrosoglutathione (GSNO). The effects of GSNO (10–500 µM) on cell growth, PGE2 production, COX-1/COX-2 protein expression and cell-cycle distribution were evaluated. GSNO increased PGE2 production and induced COX-1 and COX-2 protein expression in a dose- and time-dependent manner. Higher concentrations of GSNO also inhibited cell growth and induced apoptosis in all three cell lines, regardless of their COX-2 expression/activities. Inhibition of PGE2 production did not further improve the inhibitory effect of GSNO.

Keywords: COX, cyclooxygenase; GSNO, S-nitrosoglutathione; iNOS; inducible nitric oxide synthase; NO, nitric oxide; NOS, nitric oxide synthase; NSAID, non-steroidal anti-inflammatory drug; SEM, standard error of the mean.

Journal Article.  4104 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.